These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38378398)

  • 1. Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
    Pilon Y; Rokah M; Seitlinger J; Sepesi B; Rayes RF; Cools-Lartigue J; Najmeh S; Sirois C; Mulder D; Ferri L; Abdulkarim B; Ezer N; Fraser R; Camilleri-Broët S; Fiset PO; Wong A; Sud S; Langleben A; Agulnik J; Pepe C; Shieh B; Hirsh V; Ofiara L; Owen S; Spicer JD
    Clin Lung Cancer; 2024 May; 25(3):e133-e144.e4. PubMed ID: 38378398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.
    Huang X; Pang G; Mao Z; Li B; Teng Z; Yang Y; Qiu Z; Chen X; Wang P
    Clin Respir J; 2024 May; 18(5):e13761. PubMed ID: 38693705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Outcomes of Thoracoscopic Versus Open Lobectomy for Non-Small-Cell Lung Cancer After Neoadjuvant Therapy: A Multi-Center Retrospective Cohort Study.
    Cao J; Zhang C; Zhang X; Liu L; Li X; He J; Xu L; Fu X; Liu Y; Liu D; Hu J; Wang L
    Clin Lung Cancer; 2024 May; 25(3):e153-e160. PubMed ID: 38172025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN).
    Ahern E; Cubitt A; Ballard E; Teng MWL; Dougall WC; Smyth MJ; Godbolt D; Naidoo R; Goldrick A; Hughes BGM
    Trials; 2019 Dec; 20(1):753. PubMed ID: 31856909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
    Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
    Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
    Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
    Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.
    Appel S; Goldstein J; Perelman M; Rabin T; Urban D; Onn A; Shulimzon TR; Weiss I; Lieberman S; Marom EM; Golan N; Simansky D; Ben-Nun A; Lawrence YR; Bar J; Symon Z
    Isr Med Assoc J; 2017 Oct; 19(10):614-619. PubMed ID: 29103238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
    Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
    Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).
    Nguyen NA; Isfahanian N; Pond G; Hanna W; Cutz JC; Wright J; Swaminath A; Shargall Y; Chow T; Wierzbicki M; Okawara G; Quan K; Finley C; Juergens R; Tsakiridis T
    Clin Lung Cancer; 2017 Jul; 18(4):436-440.e1. PubMed ID: 28215851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
    Kocher F; Pircher A; Mohn-Staudner A; Romeder F; Duller W; Steinmaurer M; Eckmayr J; Schmid T; Hilbe W; Fiegl M; Greil R
    Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The Netherlands.
    Joosten PJM; Damhuis RAM; van Diessen JNA; de Langen JA; Belderbos JSA; Smit EF; Klomp HM; Veenhof AAFA; Hartemink KJ
    Acta Oncol; 2020 Jul; 59(7):748-752. PubMed ID: 32347142
    [No Abstract]   [Full Text] [Related]  

  • 17. Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.
    Zhang Y; Fu F; Hu H; Wang S; Li Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2021 Feb; 161(2):434-442.e2. PubMed ID: 32340810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP
    Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option.
    Faehling M; Fallscheer S; Kramberg S; Sträter J; Eschmann S; Sätzler R; Heinzelmann F
    Eur J Cancer; 2021 Oct; 156():175-186. PubMed ID: 34461420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.